CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer

Ava Safaroghli-azar, Travis Croft, Laychiluh B. Mekonnen, Jimma Lenjisa, Maja Dickel, Raj K. Shrestha, Samyukta Sita, Nicholas Choo, Michael Roach, Sunita K.C. Basnet, Mitchell G. Lawrence, Luke A. Selth, Shudong Wang · 2026

Read CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer by Ava Safaroghli-azar, Travis Croft, Laychiluh B. Mekonnen, Jimma Lenjisa, Maja Dickel, Raj K. Shrestha, Samyukta Sita, Nicholas Choo, Michael Roach, Sunita K.C. Basnet, Mitchell G. Lawrence, Luke A. Selth, Shudong Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520305.txt.

Description

Ava Safaroghli-azar leads a 2026 laboratory study of AU2-94, a drug designed to block only the CDK4 protein in prostate cancer. Earlier drugs block CDK4 together with CDK6, so the team tests whether a narrower drug keeps its strength while working in cancers that resist standard care.

AU2-94 slowed growth across prostate cancer cells with varied hormone sensitivity, plus organoids and mouse tumours. In cells with intact RB protein, the drug lowered RB activity and quieted growth programmes. Combinations with hormone therapy, chemotherapy and a PI3K blocker were also tested. Readers get a detailed early case for selective CDK4 blockade before any human use.

Catalog record

CREATORAva Safaroghli-azar, Travis Croft, Laychiluh B. Mekonnen, Jimma Lenjisa, Maja Dickel, Raj K. Shrestha, Samyukta Sita, Nicholas Choo, Michael Roach, Sunita K.C. Basnet, Mitchell G. Lawrence, Luke A. Selth, Shudong Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82534
LICENSEhttps://creativecommons.org/publicdomain/zero/1.0
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13520305

Browse the full library · About the Tower of Babel